Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nanometer antibody targeting rotavirus protein and application thereof

A nanobody and rotavirus technology, applied in the field of antibody technology and biomedicine, can solve the problems of high immunogenicity, long production cycle and weak penetration ability.

Active Publication Date: 2022-07-22
广州明药科技有限公司
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the rotavirus-specific antibodies prepared by the above methods are traditional monoclonal antibodies, which have the following disadvantages: long research and development cycle, long production cycle, High preparation cost, high immunogenicity, difficult to be cleared in the body, weak penetration ability
However, there is no report on the preparation of anti-rotavirus nanobody

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanometer antibody targeting rotavirus protein and application thereof
  • Nanometer antibody targeting rotavirus protein and application thereof
  • Nanometer antibody targeting rotavirus protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1. Panning of Nanobodies Targeting Rotavirus Proteins by Phage Displaying Nanobody Random Library

[0023] The phage display library was subjected to affinity panning in the manner of binding, washing, elution and amplification, and the VP8 protein of rotavirus was used as the antigen for panning anti-rotavirus nanobodies. In the experiment, non-specific adsorption was reduced by alternately unblocking and 5% milk blocking, and the coating concentration of viral protein was 10 μg / mL. The specific steps of panning are as follows: add 100 μL of viral protein antigen at a concentration of 10 μg / mL (1 μg / well) to the wells of the eight-continuous-well enzyme-labeled strip, and coat at 37°C for 2 hours. Discard the supernatant, wash the enzyme-labeled strip 5 times with 0.05% PBST, add 200 μL of 5% milk to each well when blocking, and block at 37°C for 2 hours. Discard the blocking solution, wash the enzyme-labeled strips 5 times with 0.05% PBST, and add 100 μL of p...

Embodiment 2

[0024] Embodiment 2. Identification of positive clones

[0025] A single colony was randomly picked from the titered plate for phage rescue and purification, and then positive clones were identified by ELISA. The specific steps are as follows: add 100 μL of viral protein antigen at a concentration of 10 μg / mL (1 μg / well) to the wells of the eight-continuous-well enzyme labeling strip, and coat at 37°C for 2 hours. Discard the supernatant, wash the enzyme-labeled strips 5 times with PBST, add 200 μL of 5% milk to each well, and make another strip as a negative control, block at 37°C for 2 hours. The enzyme-labeled strips were washed 5 times with PBST, 100 μL of amplified monoclonal phage suspension was added to each well, and incubated at room temperature with shaking on a shaker for 1 hour. The plate was washed 5 times with PBST, 100 μL of mouse-derived anti-HA primary antibody was added to each well, and incubated for 1 hour at room temperature with shaking on a shaker. The...

Embodiment 3

[0026] Example 3. Fusion of Nanobody Rot1 with Histidine Tag and Human Influenza Virus Hemagglutinin Tag

[0027] In the phage display library, the nanobody is fused to the capsid protein P3 of the M13 phage and displayed on the surface of the phage particle. We cut the base sequence of the obtained Nanobody Rot1 into gene fragments with restriction enzymes NdeI and XhoI, and inserted them into the pET23a plasmid, and introduced a histidine tag and human influenza virus hemagglutinin at the C-terminus of the Nanobody. The tag is convenient for the separation, purification and identification of recombinant proteins using nickel columns. The C-terminal amino acid sequence of the Nanobody Rot1 fusion protein is: GQAGQHHHHHHHGAYPYDVPDYALEHHHHHH*.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Rotavirus is a virus capable of causing acute gastrointestinal diseases (diarrhea). The invention discloses a nano antibody targeting rotavirus capsid protein as well as expression, purification and identification of the nano antibody. The nano antibody targeting the rotavirus can be used for environment monitoring of the rotavirus and clinical diagnosis and treatment of rotavirus infection.

Description

technical field [0001] The invention relates to the field of antibody technology and biomedicine, in particular to the monitoring of rotavirus transmission and the diagnosis and treatment of rotavirus-infected diseases. Background technique [0002] Rotavirus (RV) is a double-stranded RNA virus that was first discovered by an Australian scholar Ruth Bishop in 1973 using electron microscopy. It was named after its shape like a wheel. It is the leading cause of severe diarrhea in children worldwide, and it can also cause acute gastrointestinal disease in humans or animals. However, so far, there is no specific drug that can effectively treat rotavirus infection on the market. Therefore, research on a rapid and accurate early detection method for rotavirus has far-reaching significance for the prevention and treatment of the virus. [0003] Monoclonal antibodies are mainly prepared by using experimental mice as hosts. The preparation method is usually as follows: after infecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/10C07K19/00C12N7/02G01N33/569A61P31/14C12R1/93
CPCC07K16/10C12N7/00G01N33/56983A61P31/14C07K2317/569C07K2317/565C07K2317/92C07K2319/21C07K2319/42C12N2720/12351G01N2333/14G01N2469/10
Inventor 叶其壮白晓康王梓杨陈锦德肖利群
Owner 广州明药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com